Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS-Reference-Cited by-同舟云学术

Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS

Published:2019-11 Issue:11 Volume:43 Page:1574-1582
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Visser Lindy L.,Elshof Lotte E.,Van de Vijver Koen,Groen Emma J.,Almekinders Mathilde M.,Sanders Joyce,Bierman Carolien,Peters Dennis,Hofland Ingrid,Broeks Annegien,van Leeuwen Flora E.,Rutgers Emiel J. Th,Schmidt Marjanka K.,Schaapveld Michael,Lips Esther H.,Wesseling Jelle

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference47 articles.

1. Progression from ductal carcinoma in situ to invasive breast cancer: revisited;Cowell;Mol Oncol,2013

2. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci;O’Connell;J Natl Cancer Inst,1998

3. Gene amplification in ductal carcinoma in situ of the breast;Burkhardt;Breast Cancer Res Treat,2010

4. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways;Buerger;J Pathol,1999

5. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes;Buerger;J Pathol,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

2. Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer;Breast Cancer Research and Treatment;2024-03-24

3. Abstract F1-2: Clonal evolution of DCIS to invasion;Cancer Research;2023-03-01

4. Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis;Breast Cancer Research and Treatment;2022-11-24

5. Learning to distinguish progressive and non-progressive ductal carcinoma in situ;Nature Reviews Cancer;2022-10-19